← Evidence map

ArticleRheumatology advances in practice2021

Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated vasculitis.

Ruchika Goel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 34632259